Abstract
Superficial temporal artery (STA)–middle cerebral artery (MCA) bypass is the standard surgical treatment for moyamoya disease (MMD). Local cerebral hyperperfusion (CHP) is one of the potential complications, which could enhance intrinsic inflammation and oxidative stress in MMD patients and accompany concomitant watershed shift (WS) phenomenon, defined as the paradoxical decrease in the cerebral blood flow (CBF) near the site of CHP. However, CHP and simultaneous remote reversible lesion at the splenium have never been reported. A 22-year-old man with ischemic-onset MMD underwent left STA–MCA bypass. Although asymptomatic, local CHP and a paradoxical CBF decrease at the splenium were evident on N-isopropyl-p-[123I] iodoamphetamine single-photon emission computed tomography 1 day after surgery. The patient was maintained under strict blood pressure control, but he subsequently developed transient delirium 4 days after surgery. MRI revealed a high-signal-intensity lesion with a low apparent diffusion coefficient at the splenium. After continued intensive management, the splenial lesion disappeared 14 days after surgery. The patient was discharged without neurological deficits. Catheter angiography 2 months later confirmed marked regression of posterior-to-anterior collaterals via the posterior pericallosal artery, suggesting dynamic watershed shift between blood flow supplies from the posterior and anterior circulation. Mild encephalitis/encephalopathy with a reversible splenial lesion could explain the pathophysiology of the postoperative splenial lesion in this case, which is associated with generation of oxidative stress, enhanced inflammation, and metabolic abnormalities. Rapid postoperative hemodynamic changes, including local CHP and concomitant WS phenomenon, might participate in the formation of the splenial lesion.
Keywords: moyamoya disease, direct revascularization surgery, cerebral hyperperfusion, MERS, watershed shift
Introduction
Superficial temporal artery (STA)–middle cerebral artery (MCA) bypass is a standard surgical procedure for patients with moyamoya disease (MMD).1,2) However, intensive perioperative management is required to avoid perioperative complications,3–15) such as cerebral hyperperfusion (CHP)3–9) and hemodynamic ischemia due to the “watershed shift (WS) phenomenon,”10–15) defined as the paradoxical decrease in the cerebral blood flow (CBF) value near the site of CHP, as reported previously. Previous reports showed that the WS phenomenon was evident in 10.9% of adult MMD patients after STA–MCA anastomosis.13) Although the outcome of the WS phenomenon is favorable,13) the WS phenomenon could result in cerebral infarction and permanent neurological deficits.13–15) In addition, STA–MCA bypass could enhance intrinsic inflammatory response and oxidative stress response in patients with MMD,16–20) which can contribute to the formation of vasogenic edema and intracerebral hemorrhage. Then, the detection of heterogeneous hemodynamic and inflammatory changes and intensive postoperative management is critical after STA–MCA anastomosis for MMD.10,13–15) To detect heterogenous and dynamic hemodynamic changes and perform intensive management, such as prophylactic blood pressure lowering21) and administration of minocycline hydrochloride,22) we have introduced serial [123I] iodoamphetamine single-photon emission computed tomography (123I-IMP-SPECT)23,24) and MRI25) studies in the acute phase of revascularization surgery for MMD. Among 525 consecutive revascularization surgeries for MMD patients, we report a rare patient who developed local CHP and concomitant remote reversible lesion at the splenium after STA–MCA bypass, with marked regression of periallosal artery.
Case Report
A 22-year-old man with ischemic-onset MMD underwent left STA–MCA bypass. Intraoperatively, the stump of the left STA was anastomosed to the M4 segment of the left MCA (Fig. 1A and 1B). Postoperative magnetic resonance (MR) angiography confirmed patent STA–MCA bypass (Fig. 1C). Although asymptomatic, local CBF increased by over 150% from the preoperative CBF value, and a paradoxical decrease in the CBF value at the splenium was evident on N-isopropyl-p-123I-IMP-SPECT (Fig. 1D) on postoperative day (POD) 1, while no parenchymal lesions were found on MR imaging (Fig. 1E). Then we performed intensive management, such as strict blood pressure control (systolic blood pressure: 110–130 mmHg) and administration of minocycline hydrochloride, to avoid deleterious events due to CHP,1,24,25) but the patient developed delirium on POD 4. Diffusion- weighted MR imaging revealed a high-signal- intensity lesion with a low apparent diffusion coefficient at the splenium (Fig. 1F and 1G). Due to continued intensive management, he did not develop other symptoms later. We confirmed the amelioration of local CHP and the paradoxical decrease in the CBF at the splenium by 123I-IMP-SPECT on POD 7 (Fig. 1D), and of the splenium lesion on POD 14 on MR imaging (Fig. 1H). Based on the temporal profile of MR imaging, we diagnosed the splenium lesion as a reversible ischemic lesion. The patient was discharged without neurological deficits 18 days after surgery. Catheter angiography 2 months after revascularization surgery confirmed the marked regression of posterior-to-anterior collaterals via the posterior pericallosal artery, suggesting the dynamic watershed shift between blood flow supplies from the posterior and anterior circulation (Fig. 1I and 1J).
Fig. 1. Intraoperative view of left superficial temporal artery (STA)–middle cerebral artery (MCA) bypass (A). The frontal branch of the STA was anastomosed to the M4 segment of the left MCA. The arrow indicates the site of anastomosis. Indocyanine green video-angiography confirmed the patency of the bypass (B). Magnetic resonance (MR) angiography 1 day after the surgery, indicating left STA–MCA bypass as high-signal intensity (arrow) (C). [123I] iodoamphetamine single-photon emission computed tomography (123I-IMP-SPECT) before and 1 and 7 days after surgery, showing local cerebral hyperperfusion and concomitant decrease in the cerebral blood flow (CBF) at the splenium (D). The numbers represent the quantitative CBF values (ml/100 g/min) by the auto-radiographic method. Values in the parenthesis indicate the relative CBF ratio compared with the preoperative value. Temporal profile of MR images. Diffusion-weighted image (DWI) at 2 days after the surgery (E), DWI (F) and apparent diffusion coefficient (G) at 5 days after the surgery, and T2-weighted image (H) at 14 days after the surgery, together indicating the reversible ischemic lesion at the splenium. Catheter angiography before (I) and after (J) the surgery, showing regression of the posterior pericallosal artery after the surgery.
Discussion
In this study, we report the extremely rare case of adult MMD patients who manifested local CHP and concomitant reversible lesions at the splenium after STA–MCA anastomosis. Although the etiology of remote reversible lesion at splenium remains uncertain, postoperative various factors, including generation of oxidative stress and inflammation, and hemodynamic changes could explain this extremely rare manifestation of this splenial lesion.
Postoperative generation of oxidative stress and enhanced intrinsic inflammation after STA–MCA anastomosis might participate in the formation of splenial reversible lesion in the present case. Splenial lesion in this case was limited in corpus callosum and showed high-intensity signal on diffusion-weighted imaging and decreased apparent diffusion coefficient (ADC) values (Fig. 1F and 1G). Similar findings are observed in patients with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS), which develop transient consciousness disturbance and seizure.26,27) However, the manifestation of MERS after bypass surgery has never been reported. Although major etiology of MERS is viral infection, previous study demonstrated increased interleukin-6, tau proteins, and 8-hydroxy-2’-deoxyguanosine in patients with MERS, suggesting the involvement of inflammation, axonal damage, and oxidative stress in the pathophysiology of MERS.28) After STA–MCA anastomosis for MMD, rapid hemodynamic changes can cause oxidative stress and enhance intrinsic inflammation in MMD, as increased production of matrix metalloproteinase-9, CD163, and CXCL516–18) and the association between MMD and human leukocyte antigen allele19,20) have been reported. Then, we speculated that postoperative generation of oxidative stress and enhanced intrinsic inflammation, as well as hemodynamic changes could account for the reversible lesion at splenium in the present case.
Postoperative rapid hemodynamic changes could also participate in the formation of splenial lesion in the current case. Dynamic and heterogeneous hemodynamic changes are evident after STA–MCA anastomosis for MMD.3–15,29,30) In the previous reports, the WS phenomenon was defined as paradoxical decrease of CBF adjacent to the site of local CHP.10–15) On the contrary, the current case demonstrated CHP and concomitant reversible lesion at corpus callosum, which is atypical to WS phenomenon. Vascular supply to the splenium is provided by the anterior pericallosal artery, posterior pericallosal artery, and posterior accessory pericallosal artery.31,32) Although prominent regression of posterior pericallosal artery after STA–MCA anastomosis does not necessarily reflect the hemodynamic changes in the acute phase of STA–MCA anastomosis, this rapid and significant shift of watershed could partly participate in the formation of ischemia at corpus callosum. This kind of watershed shift is atypical to WS phenomenon, which is originally defined as paradoxical decrease of CBF adjacent to the site of local CHP.12–14) Then, the precise understanding of perioperative hemodynamic changes in individual cases is extremely important in the perioperative management of revascularization surgery for MMD, and serial quantitative evaluation of hemodynamic changes by 123I-IMP-SPECT is extremely useful.1,3,13,23,24) In addition, recent report demonstrated preoperative MR angiography has also diagnostic value of CHP by assessment of signal intensity of intracranial major arteries.25) Therefore, serial quantitative 123I-IMP-SPECT and MR imaging studies are useful to detect dynamic and heterogenous postoperative hemodynamic changes.
MR imaging, including ADC values, may be useful to predict whether splenial lesion is reversible or not. The ADC values significantly decrease spontaneously after the onset of focal brain ischemia. Complete or partial recovery of ADC reductions after blood flow restoration occurs in temporary focal ischemia, suggesting that early ADC reductions after focal ischemia can represent reversible ischemic brain injury. Some previous literatures suggested that ADC reductions do not accurately predict cerebral ischemia.33,34) Even significant reductions of ADC values can normalize in ischemic stroke, and ADC normalization depends on the duration and severity of ischemia rather than the absolute ADC values.35,36) In addition, splenial lesion in the present case may reflect generation of oxidative stress, inflammation, and intramyelin edema, as discussed previously.25,26) Then, ADC values could be useful to detect reversible ischemia, although not only oxidative stress and inflammatory changes but also postoperative hemodynamic changes could participate in the formation of the splenial lesion in the current case.26–28) Therefore, we strongly recommend serial quantitative 123I-IMP-SPECT and MR imaging studies to detect dynamic and heterogenous postoperative changes in patients with MMD after STA–MCA anastomosis.
Conclusions
We report a markedly rare MMD case, manifesting as transient splenial lesion with postoperative marked remission of posterior-to-anterior collaterals. Although the etiology of reversible lesion at splenium remains unknown, generation of oxidative stress and inflammation, metabolic abnormalities, and postoperative hemodynamic changes, such as local CHP and concomitant WS phenomenon, might explain the transient ischemia at splenium. Then, serial and quantitative assessment of CBF using 123I-IMP-SPECT and MR imaging studies are useful to detect dynamic and heterogeneous postoperative changes.
Acknowledgments
This study was supported by JSPS KAKENHI Grant Number 20K09362. The authors have no conflicting remarks.
Footnotes
Conflicts of Interest Disclosure
The authors have nothing to declare. The authors have registered online Self-Reported COI Disclosure Statement Forms through the website for Japan Neurosurgical Society (JNS) members.
References
- 1). Fujimura M, Tominaga T: Current status of revascularization surgery for Moyamoya disease: special consideration for its ‘internal carotid-external carotid (IC-EC) conversion’ as the physiological reorganization system. Tohoku J Exp Med 236: 45– 53, 2015 [DOI] [PubMed] [Google Scholar]
- 2). Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW: Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. J Neurosurg 128: 793– 799, 2018 [DOI] [PubMed] [Google Scholar]
- 3). Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T: Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71: 442– 447, 2009 [DOI] [PubMed] [Google Scholar]
- 4). Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T: Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery 68: 957– 964; discussion 964–965, 2011 [DOI] [PubMed] [Google Scholar]
- 5). Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T: Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery 68: 957– 964; discussion 964–965, 2011 [DOI] [PubMed] [Google Scholar]
- 6). Park W, Park ES, Lee S, et al. : Intracranial hemorrhage after superficial temporal artery-middle cerebral artery direct anastomosis for adults with moyamoya disease. World Neurosurg 119: e774– e782, 2018 [DOI] [PubMed] [Google Scholar]
- 7). Tokairin K, Kazumata K, Uchino H, et al. : Postoperative intracerebral hemorrhage after combined revascularization surgery in moyamoya disease: profiles and clinical associations. World Neurosurg 120: e593– e600, 2018 [DOI] [PubMed] [Google Scholar]
- 8). Ishikawa T, Yamaguchi K, Kawashima A, et al. : Predicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with moyamoya disease. World Neurosurg 119: e750– e756, 2018 [DOI] [PubMed] [Google Scholar]
- 9). Tashiro R, Fujimura M, Katsuki M, et al. : Prolonged/delayed cerebral hyperperfusion in adult patients with moyamoya disease with RNF213 gene polymorphism c.14576G>A (rs112735431) after superficial temporal artery-middle cerebral artery anastomosis. J Neurosurg 23: 1– 8, 2020 [DOI] [PubMed] [Google Scholar]
- 10). Kameyama M, Fujimura M, Tashiro R, et al. : Significance of quantitative cerebral blood flow measurement in the acute stage after revascularization surgery for adult moyamoya disease: implication for the pathological threshold of local cerebral hyperperfusion. Cerebrovasc Dis 48: 217– 225, 2019 [DOI] [PubMed] [Google Scholar]
- 11). Heros RC, Scott RM, Kistler JP, Ackerman RH, Conner ES: Temporary neurological deterioration after extracranial-intracranial bypass. Neurosurgery 15: 178– 185, 1984 [DOI] [PubMed] [Google Scholar]
- 12). Hayashi T, Shirane R, Fujimura M, Tominaga T: Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr 6: 73– 81, 2010 [DOI] [PubMed] [Google Scholar]
- 13). Tu XK, Fujimura M, Rashad S, et al. : Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'. Neurosurg Rev 40: 507– 512, 2017 [DOI] [PubMed] [Google Scholar]
- 14). Tashiro R, Fujimura M, Kameyama M, et al. : Incidence and risk factors of the watershed shift phenomenon after superficial temporal artery-middle cerebral artery anastomosis for adult moyamoya disease. Cerebrovasc Dis 47: 178– 187, 2019 [DOI] [PubMed] [Google Scholar]
- 15). Yu J, Hu M, Ti L, Zhou K, Zhang J, Chen J: Paradoxical association of symptomatic cerebral edema with local hypoperfusion caused by ‘watershed shift’ after revascularization surgery for adult moyamoya disease: a case report. Ther Adv Neurol Disord 12: 1756287286419878343, 2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16). Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T: Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 72: 476– 480; discussion 480, 2009 [DOI] [PubMed] [Google Scholar]
- 17). Kang HS, Kim JH, Phi JH, et al. : Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81: 673– 678, 2010 [DOI] [PubMed] [Google Scholar]
- 18). Fujimura M, Fujimura T, Kakizaki A, et al. : Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: involvement of intrinsic immune reaction in its pathogenesis. Brain Res 1679: 39– 44, 2018 [DOI] [PubMed] [Google Scholar]
- 19). Hong SH, Wang KC, Kim SK, Cho BK, Park MH: Association of HLA-DR and -DQ genes with familial moyamoya disease in Koreans. J Korean Neurosurg Soc 46: 558– 563, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20). Tashiro R, Niizuma K, Khor SS, et al. : Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: a case-control study. PLoS ONE 14: e0220858, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21). Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T: Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis 33: 436– 445, 2012 [DOI] [PubMed] [Google Scholar]
- 22). Fujimura M, Niizuma K, Inoue T, et al. : Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 74: 163– 170; discussion 170, 2014 [DOI] [PubMed] [Google Scholar]
- 23). Fujimura M, Tominaga T: Significance of cerebral blood flow analysis in the acute stage after revascularization surgery for moyamoya disease. Neurol Med Chir (Tokyo) 55: 775– 781, 2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24). Fujimura M, Niizuma K, Endo H, et al. : Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease. Neurol Res 37: 131– 138, 2015 [DOI] [PubMed] [Google Scholar]
- 25). Nishizawa T, Fujimura M, Katsuki M, et al. : Prediction of cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis by three-dimensional-time-of-flight magnetic resonance angiography in adult patients with moyamoya disease. Cerebrovasc Dis 49: 396– 403, 2020 [DOI] [PubMed] [Google Scholar]
- 26). Osuka S, Imai H, Ishikawa E, et al. : Mild encephalitis/encephalopathy with a reversible splenial lesion: evaluation by diffusion tensor imaging. Two case reports. Neurol Med Chir (Tokyo) 50: 1118– 1122, 2010 [DOI] [PubMed] [Google Scholar]
- 27). Citton V, Burlina A, Baracchini C, et al. : Apparent diffusion coefficient restriction in the white matter: going beyond acute brain territorial ischemia. Insights Imaging 3: 155– 164, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28). Miyata R, Tanuma N, Hayashi M, et al. : Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). Brain Dev 34: 124– 127, 2012 [DOI] [PubMed] [Google Scholar]
- 29). Tashiro R, Fujimura M, Endo H, Endo T, Niizuma K, Tominaga T: Biphasic development of focal cerebral hyperperfusion after revascularization surgery for adult moyamoya disease associated with autosomal dominant polycystic kidney disease. J Stroke Cerebrovasc Dis 27: 3256– 3260, 2018 [DOI] [PubMed] [Google Scholar]
- 30). Kawamura K, Fujimura M, Tashiro R, Kanoke A, Saito A, Tominaga T: Persistent local vasogenic edema with dynamic change in the regional cerebral blood flow after STA-MCA bypass for adult moyamoya disease. J Stroke Cerebrovasc Dis 29: 104625, 2020 [DOI] [PubMed] [Google Scholar]
- 31). Ture U, Yasargil MG, Kright AF: The arteries of the corpus callosum: a microsurgical anatomic study. Neurosurgery 39: 1075– 1084, 1996; discussion: 1084, 1075 [DOI] [PubMed] [Google Scholar]
- 32). Kahilogullari G, Comert A, Ozdemir M, et al. : Arterial vascularization patterns of the splenium: an anatomical study. Clin Anat 26: 675– 681, 2013 [DOI] [PubMed] [Google Scholar]
- 33). Fieshler J, Knudsen K, Kucinski T, et al. : Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 35: 514– 519, 2005 [DOI] [PubMed] [Google Scholar]
- 34). Shinoda N, Hori S, Mikami K, et al. : Utility of relative ADC ratio in patient selection for endovascular revascularization of large vessel occlusion. J Neuroradiol 44: 185– 191, 2017 [DOI] [PubMed] [Google Scholar]
- 35). Fiehler J, Foth M, Kucinski T, et al. : Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 33: 79– 86, 2002 [DOI] [PubMed] [Google Scholar]
- 36). Loh PS, Butcher KS, Parsons MW, et al. : Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis. Stroke 36: 2626– 2631, 2005 [DOI] [PubMed] [Google Scholar]

